SNGX

SNGX

USD

Soligenix Inc. Common Stock

$1.340-0.100 (-6.944%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.440

High

$1.470

Low

$1.300

Volume

0.24M

Company Fundamentals

Market Cap

11.2M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

4.32M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.09Current $1.340High $6.23

Related News

PR Newswire

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

View more
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

View more
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

View more
Soligenix Announces Closing of $7.5 Million Public Offering
PR Newswire

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

View more
Soligenix Announces Pricing of $7.5 Million Public Offering